microRNA information: hsa-let-7c-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-let-7c-5p | miRbase |
| Accession: | MIMAT0000064 | miRbase |
| Precursor name: | hsa-let-7c | miRbase |
| Precursor accession: | MI0000064 | miRbase |
| Symbol: | MIRLET7C | HGNC |
| RefSeq ID: | NR_029480 | GenBank |
| Sequence: | UGAGGUAGUAGGUUGUAUGGUU |
Reported expression in cancers: hsa-let-7c-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-let-7c-5p | breast cancer | downregulation | "To identify potential markers that can be used for ......" | 24866763 | Microarray |
| hsa-let-7c-5p | esophageal cancer | upregulation | "We measured the serum levels of miR-21 miR-145 miR ......" | 23838916 | qPCR |
| hsa-let-7c-5p | liver cancer | downregulation | "Let 7c microRNA expression and clinical significan ......" | 22289550 | Reverse transcription PCR; qPCR |
| hsa-let-7c-5p | liver cancer | downregulation | "Simultaneously 9 miRNAs were down-regulated in the ......" | 24273923 | |
| hsa-let-7c-5p | lung squamous cell cancer | downregulation | "Decreased plasma let 7c and miR 152 as noninvasive ......" | 26309587 | Reverse transcription PCR |
| hsa-let-7c-5p | lymphoma | downregulation | "In particular down-regulation of hsa-let-7c was ob ......" | 18802929 | |
| hsa-let-7c-5p | pancreatic cancer | upregulation | "Metformin up-regulated the expression of miR-26a m ......" | 22245693 | |
| hsa-let-7c-5p | prostate cancer | downregulation | "MicroRNA let 7c is downregulated in prostate cance ......" | 22479342 | qPCR; in situ hybridization |
| hsa-let-7c-5p | prostate cancer | downregulation | "In this study we examined global miRNA expression ......" | 25075250 | in situ hybridization; Microarray |
Reported cancer pathway affected by hsa-let-7c-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-let-7c-5p | endometrial cancer | cell cycle pathway | "Integrated microRNA and mRNA transcriptome sequenc ......" | 25329664 | |
| hsa-let-7c-5p | liver cancer | Apoptosis pathway | "The expression profiles of microRNAs in Huh7 hepat ......" | 20347499 | |
| hsa-let-7c-5p | liver cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA let 7c Inhibits Cell Proliferation and In ......" | 25909324 | Western blot; Luciferase |
| hsa-let-7c-5p | lung cancer | Apoptosis pathway | "A sesquiterpene lactone antrocin from Antrodia cam ......" | 23880305 | Colony formation |
| hsa-let-7c-5p | retinoblastoma | cell cycle pathway | "To investigate differential expression of microRNA ......" | 21941147 |
Reported cancer prognosis affected by hsa-let-7c-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-let-7c-5p | acute myeloid leukemia | differentiation | "miRNA let 7c promotes granulocytic differentiation ......" | 22964640 | |
| hsa-let-7c-5p | bladder cancer | progression; poor survival | "Of the eight most important progression-related mi ......" | 25990459 | |
| hsa-let-7c-5p | bladder cancer | poor survival | "We identified an eight-miRNA signature including t ......" | 25991007 | |
| hsa-let-7c-5p | colorectal cancer | metastasis | "We investigated the expression of metastasis-assoc ......" | 24653631 | |
| hsa-let-7c-5p | endometrial cancer | staging | "Integrated microRNA and mRNA transcriptome sequenc ......" | 25329664 | |
| hsa-let-7c-5p | esophageal cancer | progression; worse prognosis; poor survival | "We measured the serum levels of miR-21 miR-145 miR ......" | 23838916 | |
| hsa-let-7c-5p | liver cancer | differentiation | "Let 7c microRNA expression and clinical significan ......" | 22289550 | |
| hsa-let-7c-5p | liver cancer | progression | "MicroRNA let 7c Inhibits Cell Proliferation and In ......" | 25909324 | Western blot; Luciferase |
| hsa-let-7c-5p | lung cancer | staging; metastasis | "miRNAs were assessed by quantitative real-time PCR ......" | 19209007 | |
| hsa-let-7c-5p | lung squamous cell cancer | staging; metastasis; poor survival; motility | "MicroRNA let 7c inhibits migration and invasion of ......" | 23981581 | |
| hsa-let-7c-5p | lung squamous cell cancer | staging; metastasis; differentiation | "Decreased plasma let 7c and miR 152 as noninvasive ......" | 26309587 | |
| hsa-let-7c-5p | ovarian cancer | malignant trasformation | "Using customized TaqMan low density miRNA arrays w ......" | 27636713 | |
| hsa-let-7c-5p | pancreatic cancer | staging | "The miRNAs expression profile of early stage was s ......" | 24785459 | |
| hsa-let-7c-5p | pancreatic cancer | progression | "Up regulation of microRNA Let 7c by quercetin inhi ......" | 27521217 | Luciferase; Colony formation |
| hsa-let-7c-5p | prostate cancer | metastasis | "Change in expression of miR let7c miR 100 and miR ......" | 19372056 | |
| hsa-let-7c-5p | prostate cancer | progression; poor survival | "We performed miRNA-microarray analysis in a high-r ......" | 23798998 |
Reported gene related to hsa-let-7c-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-let-7c-5p | prostate cancer | AR | "MicroRNA let 7c suppresses androgen receptor expre ......" | 22128178 |
| hsa-let-7c-5p | thyroid cancer | ATM | "In the present study we investigated the expressio ......" | 19370508 |
| hsa-let-7c-5p | liver cancer | BCL2L1 | "Over-expression of let-7c or let-7g led to a clear ......" | 20347499 |
| hsa-let-7c-5p | liver cancer | CDC25A | "MicroRNA let 7c Inhibits Cell Proliferation and In ......" | 25909324 |
| hsa-let-7c-5p | prostate cancer | CFTR | "Validation of the data using an independent high-r ......" | 23798998 |
| hsa-let-7c-5p | breast cancer | ERBB2 | "We confirmed that miR125b directly targets HER2 an ......" | 25388283 |
| hsa-let-7c-5p | lung squamous cell cancer | ITGB3 | "MicroRNA let 7c inhibits migration and invasion of ......" | 23981581 |
| hsa-let-7c-5p | prostate cancer | LIN28A | "Furthermore let-7c expression is downregulated in ......" | 22479342 |
| hsa-let-7c-5p | breast cancer | LINC00478 | "We found 78 miRNAs differentially expressed betwee ......" | 25388283 |
| hsa-let-7c-5p | lung squamous cell cancer | MAP4K3 | "MicroRNA let 7c inhibits migration and invasion of ......" | 23981581 |
| hsa-let-7c-5p | breast cancer | MYB | "Let-7c were among the identified downregulated epi ......" | 25122196 |
| hsa-let-7c-5p | prostate cancer | MYC | "MicroRNA let 7c suppresses androgen receptor expre ......" | 22128178 |
| hsa-let-7c-5p | pancreatic cancer | NUMBL | "Up regulation of microRNA Let 7c by quercetin inhi ......" | 27521217 |
| hsa-let-7c-5p | acute myeloid leukemia | PBX2 | "Moreover we identified PBX2 a well-known homeodoma ......" | 22964640 |
| hsa-let-7c-5p | gastric cancer | PGC | "There were significant negative correlations betwe ......" | 25549793 |
| hsa-let-7c-5p | lung cancer | SOAT1 | "Additionally antrocin increased microRNA let-7c ex ......" | 23880305 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-let-7c-5p | CCNB2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.085; TCGA BRCA -0.664; TCGA COAD -0.185; TCGA ESCA -0.196; TCGA HNSC -0.203; TCGA KIRC -0.529; TCGA KIRP -0.372; TCGA LIHC -0.854; TCGA LUAD -0.617; TCGA LUSC -0.414; TCGA PRAD -0.178; TCGA THCA -0.396; TCGA STAD -0.359; TCGA UCEC -0.276 |
hsa-let-7c-5p | CCNF | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.12; TCGA BRCA -0.39; TCGA COAD -0.186; TCGA ESCA -0.107; TCGA HNSC -0.122; TCGA KIRC -0.267; TCGA KIRP -0.198; TCGA LGG -0.209; TCGA LIHC -0.504; TCGA LUAD -0.399; TCGA LUSC -0.193; TCGA PAAD -0.182; TCGA THCA -0.151; TCGA STAD -0.339; TCGA UCEC -0.176 |
hsa-let-7c-5p | CNOT3 | 10 cancers: BLCA; BRCA; COAD; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.055; TCGA BRCA -0.127; TCGA COAD -0.075; TCGA KIRC -0.07; TCGA LIHC -0.137; TCGA LUAD -0.154; TCGA LUSC -0.073; TCGA PAAD -0.208; TCGA PRAD -0.088; TCGA STAD -0.078 |
hsa-let-7c-5p | DOT1L | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.102; TCGA BRCA -0.106; TCGA COAD -0.133; TCGA ESCA -0.092; TCGA KIRC -0.109; TCGA LGG -0.203; TCGA LIHC -0.15; TCGA LUAD -0.118; TCGA PAAD -0.204; TCGA PRAD -0.173; TCGA STAD -0.182; TCGA UCEC -0.091 |
hsa-let-7c-5p | EWSR1 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.072; TCGA BRCA -0.09; TCGA COAD -0.094; TCGA HNSC -0.08; TCGA LIHC -0.076; TCGA LUAD -0.081; TCGA LUSC -0.055; TCGA PAAD -0.1; TCGA PRAD -0.071; TCGA STAD -0.116 |
hsa-let-7c-5p | FAM103A1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.097; TCGA BRCA -0.161; TCGA COAD -0.083; TCGA ESCA -0.058; TCGA HNSC -0.087; TCGA KIRC -0.058; TCGA KIRP -0.053; TCGA LIHC -0.146; TCGA LUAD -0.098; TCGA PRAD -0.075; TCGA SARC -0.051; TCGA STAD -0.086 |
hsa-let-7c-5p | FANCI | 18 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.099; TCGA BRCA -0.411; TCGA COAD -0.169; TCGA ESCA -0.154; TCGA HNSC -0.131; TCGA KIRC -0.238; TCGA KIRP -0.141; TCGA LGG -0.232; TCGA LIHC -0.553; TCGA LUAD -0.401; TCGA LUSC -0.273; TCGA OV -0.09; TCGA PAAD -0.163; TCGA PRAD -0.089; TCGA SARC -0.13; TCGA THCA -0.431; TCGA STAD -0.269; TCGA UCEC -0.154 |
hsa-let-7c-5p | GPS1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.084; TCGA BRCA -0.209; TCGA CESC -0.072; TCGA COAD -0.116; TCGA ESCA -0.088; TCGA HNSC -0.085; TCGA LGG -0.062; TCGA LIHC -0.069; TCGA LUAD -0.106; TCGA LUSC -0.07; TCGA OV -0.056; TCGA PAAD -0.268; TCGA THCA -0.056; TCGA STAD -0.074; TCGA UCEC -0.058 |
hsa-let-7c-5p | GSK3A | 9 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.059; TCGA BRCA -0.154; TCGA COAD -0.076; TCGA LIHC -0.102; TCGA LUAD -0.116; TCGA LUSC -0.071; TCGA PAAD -0.113; TCGA THCA -0.057; TCGA STAD -0.073 |
hsa-let-7c-5p | IVNS1ABP | 9 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.076; TCGA CESC -0.054; TCGA COAD -0.059; TCGA HNSC -0.154; TCGA KIRP -0.089; TCGA LUAD -0.082; TCGA LUSC -0.057; TCGA STAD -0.189; TCGA UCEC -0.158 |
hsa-let-7c-5p | MESDC1 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; OV; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.069; TCGA BRCA -0.15; TCGA CESC -0.081; TCGA COAD -0.114; TCGA ESCA -0.178; TCGA OV -0.078; TCGA PRAD -0.081; TCGA THCA -0.056; TCGA STAD -0.114 |
hsa-let-7c-5p | PAK4 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.085; TCGA BRCA -0.216; TCGA CESC -0.055; TCGA COAD -0.106; TCGA ESCA -0.062; TCGA LIHC -0.146; TCGA LUAD -0.115; TCGA LUSC -0.116; TCGA PAAD -0.25; TCGA STAD -0.125 |
hsa-let-7c-5p | PCGF3 | 10 cancers: BLCA; BRCA; COAD; KIRC; LGG; LIHC; LUAD; PAAD; PRAD; STAD | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.186; TCGA BRCA -0.051; TCGA COAD -0.076; TCGA KIRC -0.189; TCGA LGG -0.122; TCGA LIHC -0.114; TCGA LUAD -0.169; TCGA PAAD -0.188; TCGA PRAD -0.092; TCGA STAD -0.06 |
hsa-let-7c-5p | PTGES2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.086; TCGA BRCA -0.186; TCGA CESC -0.082; TCGA COAD -0.181; TCGA ESCA -0.23; TCGA HNSC -0.096; TCGA KIRP -0.059; TCGA LGG -0.14; TCGA LIHC -0.15; TCGA LUAD -0.2; TCGA LUSC -0.223; TCGA OV -0.078; TCGA PAAD -0.254; TCGA PRAD -0.074; TCGA THCA -0.122; TCGA STAD -0.22; TCGA UCEC -0.122 |
hsa-let-7c-5p | PTK2 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; STAD | miRNAWalker2 validate | TCGA BLCA -0.113; TCGA BRCA -0.146; TCGA CESC -0.057; TCGA ESCA -0.091; TCGA HNSC -0.08; TCGA KIRP -0.08; TCGA LIHC -0.112; TCGA LUAD -0.054; TCGA PRAD -0.114; TCGA SARC -0.076; TCGA STAD -0.09 |
hsa-let-7c-5p | RAPGEFL1 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; STAD | miRNAWalker2 validate | TCGA BLCA -0.323; TCGA BRCA -0.233; TCGA COAD -0.144; TCGA KIRC -0.426; TCGA KIRP -0.315; TCGA LGG -0.256; TCGA LIHC -0.105; TCGA LUAD -0.234; TCGA LUSC -0.307; TCGA STAD -0.249 |
hsa-let-7c-5p | RPL18A | 10 cancers: BLCA; CESC; COAD; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.066; TCGA CESC -0.093; TCGA COAD -0.078; TCGA KIRP -0.164; TCGA LGG -0.164; TCGA LIHC -0.184; TCGA LUSC -0.105; TCGA PAAD -0.164; TCGA PRAD -0.182; TCGA THCA -0.164 |
hsa-let-7c-5p | RPS24 | 10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA | miRNAWalker2 validate | TCGA BLCA -0.065; TCGA CESC -0.067; TCGA HNSC -0.083; TCGA KIRC -0.14; TCGA KIRP -0.178; TCGA LGG -0.147; TCGA LIHC -0.197; TCGA LUAD -0.08; TCGA LUSC -0.087; TCGA THCA -0.071 |
hsa-let-7c-5p | SF3B4 | 12 cancers: BLCA; BRCA; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.066; TCGA BRCA -0.181; TCGA COAD -0.078; TCGA KIRP -0.053; TCGA LGG -0.096; TCGA LIHC -0.219; TCGA LUAD -0.17; TCGA LUSC -0.134; TCGA PAAD -0.117; TCGA PRAD -0.085; TCGA STAD -0.067; TCGA UCEC -0.083 |
hsa-let-7c-5p | SLC25A1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.133; TCGA BRCA -0.066; TCGA CESC -0.064; TCGA COAD -0.168; TCGA HNSC -0.09; TCGA LGG -0.092; TCGA LUAD -0.114; TCGA LUSC -0.155; TCGA PAAD -0.196; TCGA SARC -0.068; TCGA STAD -0.157; TCGA UCEC -0.134 |
hsa-let-7c-5p | SMARCD1 | 9 cancers: BLCA; COAD; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.056; TCGA COAD -0.063; TCGA HNSC -0.073; TCGA LGG -0.148; TCGA LIHC -0.178; TCGA LUAD -0.088; TCGA PAAD -0.142; TCGA PRAD -0.152; TCGA STAD -0.08 |
hsa-let-7c-5p | TAZ | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.087; TCGA BRCA -0.098; TCGA COAD -0.079; TCGA ESCA -0.085; TCGA HNSC -0.131; TCGA KIRC -0.16; TCGA LGG -0.117; TCGA LIHC -0.161; TCGA LUAD -0.147; TCGA LUSC -0.122; TCGA PAAD -0.204; TCGA PRAD -0.144; TCGA THCA -0.12; TCGA STAD -0.052; TCGA UCEC -0.107 |
hsa-let-7c-5p | TMEM165 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.127; TCGA BRCA -0.147; TCGA CESC -0.079; TCGA COAD -0.071; TCGA HNSC -0.07; TCGA KIRC -0.115; TCGA KIRP -0.064; TCGA LIHC -0.145; TCGA LUAD -0.086; TCGA SARC -0.062; TCGA THCA -0.113; TCGA STAD -0.161; TCGA UCEC -0.133 |
hsa-let-7c-5p | TMEM184B | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.069; TCGA BRCA -0.094; TCGA CESC -0.077; TCGA ESCA -0.093; TCGA HNSC -0.094; TCGA LGG -0.065; TCGA LIHC -0.171; TCGA PAAD -0.137; TCGA THCA -0.112; TCGA STAD -0.061; TCGA UCEC -0.127 |
hsa-let-7c-5p | TUT1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD | miRNAWalker2 validate | TCGA BLCA -0.072; TCGA BRCA -0.088; TCGA COAD -0.067; TCGA ESCA -0.074; TCGA HNSC -0.052; TCGA LGG -0.141; TCGA LUAD -0.093; TCGA LUSC -0.054; TCGA PAAD -0.117; TCGA PRAD -0.102; TCGA STAD -0.071 |
hsa-let-7c-5p | ZNF581 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA | miRNAWalker2 validate | TCGA BLCA -0.09; TCGA BRCA -0.125; TCGA CESC -0.121; TCGA COAD -0.063; TCGA HNSC -0.102; TCGA KIRC -0.117; TCGA KIRP -0.164; TCGA LIHC -0.316; TCGA LUAD -0.09; TCGA LUSC -0.085; TCGA PAAD -0.221; TCGA PRAD -0.126; TCGA THCA -0.287 |
hsa-let-7c-5p | ANKRD49 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC | MirTarget | TCGA BLCA -0.107; TCGA CESC -0.085; TCGA COAD -0.071; TCGA ESCA -0.071; TCGA HNSC -0.088; TCGA KIRC -0.091; TCGA LIHC -0.101; TCGA LUAD -0.085; TCGA LUSC -0.074; TCGA PRAD -0.076; TCGA SARC -0.056 |
hsa-let-7c-5p | AP1S1 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.142; TCGA BRCA -0.239; TCGA COAD -0.144; TCGA ESCA -0.122; TCGA HNSC -0.157; TCGA KIRP -0.129; TCGA LGG -0.198; TCGA LIHC -0.068; TCGA LUAD -0.123; TCGA LUSC -0.177; TCGA PAAD -0.197; TCGA THCA -0.267; TCGA STAD -0.225; TCGA UCEC -0.125 |
hsa-let-7c-5p | DCAF15 | 11 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.101; TCGA BRCA -0.076; TCGA COAD -0.105; TCGA HNSC -0.082; TCGA LGG -0.073; TCGA LIHC -0.101; TCGA LUAD -0.098; TCGA LUSC -0.106; TCGA PAAD -0.183; TCGA PRAD -0.128; TCGA STAD -0.081 |
hsa-let-7c-5p | PARD6B | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.125; TCGA BRCA -0.418; TCGA CESC -0.117; TCGA COAD -0.164; TCGA ESCA -0.263; TCGA LIHC -0.142; TCGA PRAD -0.089; TCGA SARC -0.3; TCGA STAD -0.202 |
hsa-let-7c-5p | ESPL1 | 13 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.128; TCGA BRCA -0.608; TCGA COAD -0.161; TCGA KIRC -0.24; TCGA KIRP -0.212; TCGA LGG -0.328; TCGA LIHC -0.454; TCGA LUAD -0.767; TCGA LUSC -0.359; TCGA PRAD -0.31; TCGA THCA -0.523; TCGA STAD -0.341; TCGA UCEC -0.308 |
hsa-let-7c-5p | CDC34 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.117; TCGA BRCA -0.147; TCGA COAD -0.126; TCGA ESCA -0.099; TCGA HNSC -0.105; TCGA KIRP -0.081; TCGA LUAD -0.22; TCGA LUSC -0.093; TCGA PAAD -0.323; TCGA THCA -0.176; TCGA STAD -0.081; TCGA UCEC -0.072 |
hsa-let-7c-5p | BZW2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.069; TCGA BRCA -0.129; TCGA CESC -0.122; TCGA COAD -0.111; TCGA ESCA -0.213; TCGA KIRC -0.144; TCGA KIRP -0.072; TCGA LGG -0.301; TCGA LIHC -0.203; TCGA LUAD -0.171; TCGA LUSC -0.159; TCGA PRAD -0.321; TCGA THCA -0.063; TCGA STAD -0.242 |
hsa-let-7c-5p | TTLL4 | 10 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.053; TCGA COAD -0.079; TCGA ESCA -0.115; TCGA KIRC -0.126; TCGA KIRP -0.094; TCGA LIHC -0.45; TCGA LUAD -0.156; TCGA PRAD -0.107; TCGA STAD -0.187; TCGA UCEC -0.113 |
hsa-let-7c-5p | MDFI | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA | MirTarget | TCGA BLCA -0.153; TCGA CESC -0.154; TCGA HNSC -0.334; TCGA KIRP -0.384; TCGA LIHC -0.45; TCGA LUAD -0.271; TCGA LUSC -0.16; TCGA PRAD -0.537; TCGA THCA -0.259 |
hsa-let-7c-5p | CDC25A | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.106; TCGA BRCA -0.484; TCGA CESC -0.123; TCGA COAD -0.222; TCGA ESCA -0.206; TCGA HNSC -0.084; TCGA LGG -0.215; TCGA LIHC -0.515; TCGA LUAD -0.547; TCGA LUSC -0.315; TCGA PAAD -0.351; TCGA SARC -0.082; TCGA THCA -0.109; TCGA STAD -0.433; TCGA UCEC -0.19 |
hsa-let-7c-5p | ABCB9 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | MirTarget | TCGA BLCA -0.07; TCGA BRCA -0.251; TCGA COAD -0.116; TCGA HNSC -0.063; TCGA KIRC -0.214; TCGA KIRP -0.116; TCGA LGG -0.101; TCGA LIHC -0.274; TCGA LUAD -0.193; TCGA LUSC -0.133; TCGA PAAD -0.237; TCGA THCA -0.078 |
hsa-let-7c-5p | MARS2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.11; TCGA BRCA -0.11; TCGA CESC -0.085; TCGA COAD -0.137; TCGA ESCA -0.151; TCGA KIRP -0.116; TCGA LUAD -0.139; TCGA LUSC -0.152; TCGA PRAD -0.1; TCGA SARC -0.073; TCGA STAD -0.238; TCGA UCEC -0.063 |
hsa-let-7c-5p | RAB11FIP4 | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.205; TCGA BRCA -0.268; TCGA COAD -0.114; TCGA ESCA -0.218; TCGA LIHC -0.367; TCGA PRAD -0.258; TCGA THCA -0.065; TCGA STAD -0.223; TCGA UCEC -0.136 |
hsa-let-7c-5p | ZC3H3 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.085; TCGA BRCA -0.201; TCGA CESC -0.051; TCGA COAD -0.104; TCGA HNSC -0.087; TCGA KIRC -0.12; TCGA LGG -0.1; TCGA LIHC -0.199; TCGA LUAD -0.176; TCGA LUSC -0.097; TCGA PAAD -0.192; TCGA PRAD -0.078; TCGA STAD -0.123; TCGA UCEC -0.1 |
hsa-let-7c-5p | RPUSD3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.078; TCGA BRCA -0.143; TCGA CESC -0.051; TCGA COAD -0.12; TCGA ESCA -0.106; TCGA HNSC -0.054; TCGA LGG -0.111; TCGA LUAD -0.081; TCGA LUSC -0.145; TCGA PAAD -0.159; TCGA SARC -0.058; TCGA THCA -0.107; TCGA STAD -0.096; TCGA UCEC -0.079 |
hsa-let-7c-5p | RPUSD2 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.093; TCGA BRCA -0.093; TCGA CESC -0.064; TCGA COAD -0.115; TCGA HNSC -0.054; TCGA LGG -0.099; TCGA LUSC -0.11; TCGA PAAD -0.09; TCGA PRAD -0.09; TCGA STAD -0.094 |
hsa-let-7c-5p | ELF4 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; THCA; STAD | MirTarget | TCGA BLCA -0.134; TCGA BRCA -0.073; TCGA ESCA -0.111; TCGA HNSC -0.096; TCGA KIRC -0.147; TCGA KIRP -0.202; TCGA LIHC -0.136; TCGA LUSC -0.112; TCGA THCA -0.426; TCGA STAD -0.116 |
hsa-let-7c-5p | ABCC10 | 9 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.121; TCGA BRCA -0.059; TCGA COAD -0.053; TCGA LIHC -0.302; TCGA LUAD -0.141; TCGA LUSC -0.108; TCGA PAAD -0.097; TCGA PRAD -0.147; TCGA STAD -0.069 |
hsa-let-7c-5p | STX3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.131; TCGA BRCA -0.178; TCGA CESC -0.128; TCGA COAD -0.147; TCGA ESCA -0.286; TCGA HNSC -0.141; TCGA LIHC -0.201; TCGA PRAD -0.163; TCGA SARC -0.163; TCGA THCA -0.167; TCGA STAD -0.185; TCGA UCEC -0.202 |
hsa-let-7c-5p | GRPEL2 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.079; TCGA BRCA -0.144; TCGA COAD -0.118; TCGA HNSC -0.053; TCGA KIRC -0.078; TCGA KIRP -0.101; TCGA LGG -0.218; TCGA LIHC -0.167; TCGA LUSC -0.143; TCGA PAAD -0.065; TCGA PRAD -0.061; TCGA SARC -0.091; TCGA STAD -0.091 |
hsa-let-7c-5p | PRSS22 | 9 cancers: BLCA; BRCA; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.263; TCGA BRCA -0.241; TCGA LUAD -0.15; TCGA LUSC -0.336; TCGA OV -0.225; TCGA PRAD -0.159; TCGA THCA -0.209; TCGA STAD -0.232; TCGA UCEC -0.46 |
hsa-let-7c-5p | HMGA1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.114; TCGA BRCA -0.3; TCGA CESC -0.136; TCGA COAD -0.212; TCGA ESCA -0.155; TCGA HNSC -0.151; TCGA KIRP -0.13; TCGA LIHC -0.518; TCGA LUAD -0.434; TCGA LUSC -0.338; TCGA PAAD -0.243; TCGA SARC -0.153; TCGA THCA -0.169; TCGA STAD -0.278; TCGA UCEC -0.284 |
hsa-let-7c-5p | SLC20A1 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.229; TCGA BRCA -0.151; TCGA CESC -0.15; TCGA ESCA -0.161; TCGA HNSC -0.219; TCGA KIRC -0.209; TCGA KIRP -0.289; TCGA LUAD -0.22; TCGA LUSC -0.135; TCGA OV -0.087; TCGA PRAD -0.086; TCGA SARC -0.172; TCGA THCA -0.464; TCGA STAD -0.102; TCGA UCEC -0.107 |
hsa-let-7c-5p | NME6 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.08; TCGA BRCA -0.112; TCGA CESC -0.072; TCGA COAD -0.094; TCGA ESCA -0.123; TCGA KIRP -0.085; TCGA LIHC -0.215; TCGA LUAD -0.09; TCGA PAAD -0.103; TCGA THCA -0.148; TCGA STAD -0.104; TCGA UCEC -0.068 |
hsa-let-7c-5p | CLDN12 | 9 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.085; TCGA CESC -0.059; TCGA COAD -0.155; TCGA ESCA -0.264; TCGA LUAD -0.181; TCGA LUSC -0.059; TCGA PAAD -0.15; TCGA THCA -0.16; TCGA STAD -0.209 |
hsa-let-7c-5p | FAM104A | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD | MirTarget | TCGA BLCA -0.062; TCGA BRCA -0.149; TCGA COAD -0.093; TCGA HNSC -0.067; TCGA KIRC -0.076; TCGA KIRP -0.084; TCGA LGG -0.076; TCGA LIHC -0.102; TCGA LUAD -0.133; TCGA LUSC -0.084; TCGA OV -0.081; TCGA PAAD -0.131; TCGA STAD -0.058 |
hsa-let-7c-5p | PTBP1 | 10 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | RAID | TCGA BLCA -0.093; TCGA BRCA -0.151; TCGA COAD -0.101; TCGA LIHC -0.086; TCGA LUAD -0.116; TCGA LUSC -0.065; TCGA PAAD -0.153; TCGA PRAD -0.098; TCGA STAD -0.143; TCGA UCEC -0.05 |
hsa-let-7c-5p | CSNK2A1 | 9 cancers: BRCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.113; TCGA ESCA -0.099; TCGA KIRP -0.061; TCGA LGG -0.076; TCGA LIHC -0.118; TCGA LUAD -0.088; TCGA LUSC -0.099; TCGA PRAD -0.11; TCGA STAD -0.111 |
hsa-let-7c-5p | GARS | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.145; TCGA CESC -0.083; TCGA COAD -0.107; TCGA ESCA -0.148; TCGA HNSC -0.137; TCGA KIRC -0.115; TCGA KIRP -0.11; TCGA LIHC -0.162; TCGA LUAD -0.224; TCGA LUSC -0.199; TCGA PAAD -0.175; TCGA THCA -0.319; TCGA STAD -0.185; TCGA UCEC -0.116 |
hsa-let-7c-5p | GORASP2 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.099; TCGA CESC -0.06; TCGA COAD -0.058; TCGA ESCA -0.058; TCGA KIRC -0.066; TCGA KIRP -0.079; TCGA LIHC -0.079; TCGA LUAD -0.123; TCGA LUSC -0.091; TCGA PAAD -0.055; TCGA STAD -0.114 |
hsa-let-7c-5p | LDHA | 13 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.158; TCGA CESC -0.17; TCGA COAD -0.161; TCGA HNSC -0.243; TCGA KIRC -0.14; TCGA KIRP -0.141; TCGA LUAD -0.242; TCGA LUSC -0.203; TCGA PRAD -0.208; TCGA SARC -0.138; TCGA THCA -0.289; TCGA STAD -0.163; TCGA UCEC -0.221 |
hsa-let-7c-5p | PSMB2 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.117; TCGA COAD -0.1; TCGA HNSC -0.151; TCGA KIRC -0.094; TCGA KIRP -0.064; TCGA LUAD -0.077; TCGA PAAD -0.098; TCGA THCA -0.142; TCGA STAD -0.147; TCGA UCEC -0.096 |
hsa-let-7c-5p | ZNF526 | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.06; TCGA CESC -0.074; TCGA HNSC -0.056; TCGA KIRP -0.055; TCGA LIHC -0.148; TCGA LUAD -0.082; TCGA LUSC -0.051; TCGA PAAD -0.095; TCGA THCA -0.057 |
hsa-let-7c-5p | ENTPD7 | 11 cancers: BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.126; TCGA CESC -0.186; TCGA ESCA -0.088; TCGA HNSC -0.151; TCGA LUAD -0.2; TCGA LUSC -0.148; TCGA OV -0.095; TCGA PRAD -0.146; TCGA THCA -0.096; TCGA STAD -0.093; TCGA UCEC -0.145 |
hsa-let-7c-5p | SEMA4F | 9 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; THCA | MirTarget | TCGA BRCA -0.059; TCGA CESC -0.078; TCGA HNSC -0.195; TCGA KIRP -0.122; TCGA LGG -0.199; TCGA LIHC -0.273; TCGA LUSC -0.112; TCGA PAAD -0.123; TCGA THCA -0.079 |
hsa-let-7c-5p | IGF2BP1 | 9 cancers: BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; SARC; UCEC | MirTarget; RAID | TCGA BRCA -0.305; TCGA CESC -0.577; TCGA HNSC -0.464; TCGA LIHC -1.643; TCGA LUAD -0.933; TCGA LUSC -0.421; TCGA OV -0.298; TCGA SARC -0.606; TCGA UCEC -0.325 |
hsa-let-7c-5p | TSEN34 | 11 cancers: BRCA; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD | MirTarget | TCGA BRCA -0.192; TCGA COAD -0.076; TCGA HNSC -0.064; TCGA KIRP -0.071; TCGA LIHC -0.085; TCGA LUAD -0.135; TCGA LUSC -0.084; TCGA OV -0.06; TCGA PAAD -0.228; TCGA THCA -0.06; TCGA STAD -0.065 |
hsa-let-7c-5p | SUB1 | 9 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; PRAD; THCA; STAD | MirTarget | TCGA BRCA -0.116; TCGA COAD -0.067; TCGA HNSC -0.139; TCGA KIRP -0.064; TCGA LGG -0.154; TCGA LIHC -0.152; TCGA PRAD -0.103; TCGA THCA -0.057; TCGA STAD -0.066 |
hsa-let-7c-5p | AEN | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.092; TCGA CESC -0.107; TCGA COAD -0.164; TCGA ESCA -0.193; TCGA HNSC -0.105; TCGA LGG -0.312; TCGA LUAD -0.121; TCGA LUSC -0.053; TCGA PAAD -0.098; TCGA THCA -0.197; TCGA STAD -0.178; TCGA UCEC -0.071 |
hsa-let-7c-5p | SLC17A9 | 13 cancers: BRCA; CESC; ESCA; KIRC; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.346; TCGA CESC -0.165; TCGA ESCA -0.584; TCGA KIRC -0.55; TCGA LIHC -0.199; TCGA LUAD -0.397; TCGA LUSC -0.114; TCGA OV -0.141; TCGA PAAD -0.236; TCGA SARC -0.277; TCGA THCA -0.299; TCGA STAD -0.202; TCGA UCEC -0.25 |
hsa-let-7c-5p | CASP3 | 10 cancers: BRCA; COAD; ESCA; KIRC; LUAD; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.132; TCGA COAD -0.09; TCGA ESCA -0.095; TCGA KIRC -0.15; TCGA LUAD -0.075; TCGA OV -0.103; TCGA PRAD -0.085; TCGA THCA -0.098; TCGA STAD -0.197; TCGA UCEC -0.113 |
hsa-let-7c-5p | SLC25A32 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; STAD | MirTarget | TCGA BRCA -0.084; TCGA CESC -0.079; TCGA ESCA -0.106; TCGA HNSC -0.125; TCGA KIRP -0.078; TCGA LGG -0.08; TCGA LUAD -0.097; TCGA LUSC -0.062; TCGA OV -0.073; TCGA STAD -0.117 |
hsa-let-7c-5p | DLGAP4 | 9 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; THCA | MirTarget | TCGA BRCA -0.069; TCGA ESCA -0.063; TCGA HNSC -0.117; TCGA KIRC -0.163; TCGA LGG -0.153; TCGA LIHC -0.178; TCGA LUAD -0.101; TCGA PAAD -0.225; TCGA THCA -0.164 |
hsa-let-7c-5p | RAD18 | 12 cancers: BRCA; CESC; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.09; TCGA CESC -0.081; TCGA COAD -0.132; TCGA ESCA -0.152; TCGA KIRP -0.133; TCGA LIHC -0.162; TCGA LUAD -0.15; TCGA LUSC -0.1; TCGA SARC -0.129; TCGA THCA -0.08; TCGA STAD -0.189; TCGA UCEC -0.051 |
hsa-let-7c-5p | E2F2 | 11 cancers: BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.502; TCGA COAD -0.267; TCGA KIRC -0.372; TCGA KIRP -0.213; TCGA LIHC -0.606; TCGA LUAD -0.455; TCGA LUSC -0.184; TCGA PRAD -0.232; TCGA THCA -0.404; TCGA STAD -0.417; TCGA UCEC -0.353 |
hsa-let-7c-5p | EIF4A3 | 11 cancers: BRCA; CESC; COAD; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD | RAID | TCGA BRCA -0.192; TCGA CESC -0.061; TCGA COAD -0.119; TCGA KIRP -0.061; TCGA LIHC -0.09; TCGA LUAD -0.17; TCGA LUSC -0.156; TCGA OV -0.067; TCGA PAAD -0.083; TCGA PRAD -0.055; TCGA STAD -0.151 |
hsa-let-7c-5p | RPS13 | 10 cancers: CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.066; TCGA COAD -0.093; TCGA HNSC -0.071; TCGA KIRC -0.108; TCGA KIRP -0.147; TCGA LGG -0.158; TCGA LIHC -0.102; TCGA PRAD -0.123; TCGA THCA -0.079; TCGA STAD -0.076 |
hsa-let-7c-5p | CERCAM | 9 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; UCEC | MirTarget | TCGA CESC -0.134; TCGA HNSC -0.257; TCGA KIRP -0.289; TCGA LGG -0.128; TCGA LIHC -0.138; TCGA LUAD -0.167; TCGA LUSC -0.165; TCGA OV -0.142; TCGA UCEC -0.114 |
hsa-let-7c-5p | SLC5A6 | 12 cancers: CESC; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.062; TCGA ESCA -0.139; TCGA KIRC -0.088; TCGA KIRP -0.118; TCGA LGG -0.085; TCGA LUAD -0.223; TCGA LUSC -0.183; TCGA PAAD -0.1; TCGA PRAD -0.181; TCGA THCA -0.075; TCGA STAD -0.186; TCGA UCEC -0.144 |
hsa-let-7c-5p | IGF2BP2 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; STAD | MirTarget | TCGA CESC -0.404; TCGA COAD -0.118; TCGA ESCA -0.341; TCGA HNSC -0.528; TCGA KIRC -0.408; TCGA LIHC -0.67; TCGA LUAD -0.213; TCGA LUSC -0.375; TCGA STAD -0.256 |
hsa-let-7c-5p | MXD1 | 9 cancers: COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA COAD -0.133; TCGA HNSC -0.078; TCGA KIRC -0.152; TCGA KIRP -0.114; TCGA LGG -0.09; TCGA LUAD -0.147; TCGA LUSC -0.159; TCGA STAD -0.141; TCGA UCEC -0.124 |
Enriched cancer pathways of putative targets